GSC
CURX

Ground Swell Capital’s Curanex Pharmaceuticals CURX Stock Holding History

Ground Swell Capital’s Portfolio CURX Stock Details CURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.35K Buy
+12,638
New +$4.6K ﹤0.01% 138

Other funds holding CURX

VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Ground Swell Capital's CURX Position: Q2 2026 in Review

Ground Swell Capital opened a new position in Curanex Pharmaceuticals (CURX) in Q2 2026: 12,638 shares worth $3.35K. The stake represents ﹤0.01% of the portfolio and ranks #138 among its holdings.

6 funds tracked by Wall St. Rank hold CURX as of Q2 2026.

  • Ground Swell Capital held 12,638 shares of Curanex Pharmaceuticals worth $3.35K as of Q2 2026.
  • Curanex Pharmaceuticals was a new Ground Swell Capital position in Q2 2026.
  • Curanex Pharmaceuticals made up ﹤0.01% of Ground Swell Capital's portfolio in Q2 2026, its #138 holding.
  • 6 funds tracked by Wall St. Rank held Curanex Pharmaceuticals as of Q2 2026.

Based on Ground Swell Capital's 13F filing for Q2 2026, filed 5 Aug 2026.